Researchers compared people with HIV initiating antiretroviral therapy (ART) with demographically matched people who do not have HIV and did not receive ART to determine whether HIV-specific factors, such...
Individuals with HIV are at higher risk of severe disease from COVID-19. In a recent study, researchers aimed to examine the factors that influence COVID-19 vaccine uptake in this patient population.
Pre-exposure prophylaxis (PrEP) adherence continues to be one of the main challenges for the elimination of HIV transmission. Researchers tested the use of an automated directly observed therapy...
Did you get the chance to view our Multidisciplinary Roundtable on some hot topics in treating patients with HIV? Here are some highlights that you may have missed.
To better understand the relationship between cardiovascular disease and liver disease in individuals with HIV, researchers examined both traditional risk factors and HIV-specific risk factors of the...
Researchers evaluated the impact an intensified dose of dolutegravir had on patients living with HIV. Their research was presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2023...
To better understand the relationship between vaccination and PASC risk in this patient population, researchers utilized the TriNetX health research database. Data from more than 3 million adults who tested...
